Normalizing HPV Vaccination in Preteens With a Serious Video Game

Completed · Not applicable

Conditions studied: Human Papillomavirus

In brief

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States and causes genital warts and cancers in both females and males. Vaccination against HPV is recommended for routine use in those aged 11-12 years old, yet is underutilized. The study's premise is that preteens are relevant decision makers who can be motivated to initiate and complete the HPV vaccine series (assuming parental consent and provider recommendation). This study evaluates a serious video game to engage preteens in the decision to pursue HPV vaccination. The hypothesis is that preteens who are assigned to the video game will be more likely to initiate and complete HPV vaccination than preteens who are not assigned to the video game.

Key facts

Study ID

NCT04627298

Run by

University of North Carolina, Chapel Hill

People needed

55

Starts

2015-07-09

Expected to finish

2019-04-16

Last updated by the study team

2020-11-13

Who can join

Age: 11 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• preteens 11-12 who had not received any doses of HPV vaccination
• recruited by primary care practices in North Carolina
• parent signed HIPAA release
• willing to take baseline and postintervention surveys
• access to internet and mobile device or personal computer

You may not qualify if…

• preteens who had received at least one dose of HPV vaccine

Where it is running

• Joan R, Cates — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.